Ambisome plus miltefosine for Indian patients with kala-azar

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 105, Issue 2, 2011, Pages 115-117

  Sundar, Shyam ^a   Sinha, Prabhat Kumar ^b   Verma, Deepak K ^a   Kumar, Nawin ^b   Alam, Shahnawaj ^a   Pandey, Krishna ^b   Kumari, Poonam ^a   Ravidas, Vidyanand ^b   Chakravarty, Jaya ^a   Verma, Neena ^b   Berman, Jonathan ^c   Ghalib, Hashim ^d   Arana, Byron ^d  

^a BANARAS HINDU UNIVERSITY   (India)

^b RAJENDRA MEMORIAL RESEARCH INSTITUTE OF MEDICAL SCIENCES   (India)

^c Fast Track Drugs and Biologies LLC   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Ambisome; Combination therapy; Efficacy; Kala azar; Miltefosine; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; MILTEFOSINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACKACHE; CHILD; CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; DRUG FEVER; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INDIAN; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RIGOR; SCHOOL CHILD; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFUSIONS, INTRAVENOUS; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; TREATMENT OUTCOME; YOUNG ADULT;

NASO HEXACANTHUS;

EID: 78651494011     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2010.10.008     Document Type: Article

References (4)

1. Sundar S., Chakravarty J., Agarwal D., Rai M., Murray H.W. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med 2010, 362:504-512.
2. Sundar S., Jha T.K., Thakur C.P., Engel J., Sindermann H., Fischer C., et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002, 347:1739-1746.
3. Sundar S., Jha T.K., Thakur C.P., Sinha P.K., Bhattacharya S.K. Injectable paromomycin for visceral leishmaniasis in India. N Engl J Med 2007, 356:2571-2581.
4. Sundar S., Rai M., Chakravarty J., Agarwal D., Agrawal N., Vaillant M., et al. New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clin Infect Dis 2008, 47:1000-1006.